Doxapram and hypokalaemia in very preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 98, Issue 5, 2013, Pages

  Fischer, Céline ^a   Ferdynus, Cyril ^a   Gouyon, Jean Bernard ^a   Semama, Denis S ^a  

^a Medical University of Dijon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; CORTICOSTEROID; DOXAPRAM; FUROSEMIDE; IBUPROFEN; INSULIN; POTASSIUM;

APNEA; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DUCTUS ARTERIOSUS; EDEMA; EXTUBATION; FEMALE; GESTATIONAL AGE; HOSPITALIZED INFANT; HUMAN; HYPOKALEMIA; INFANT; INTENSIVE CARE UNIT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; POSTNATAL CARE; POTASSIUM BLOOD LEVEL; POTASSIUM INTAKE; POTASSIUM METABOLISM; PREMATURITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

NEONATOLOGY; THERAPEUTICS;

ANALYSIS OF VARIANCE; APNEA; DIURETICS; DOXAPRAM; FEMALE; FUROSEMIDE; HUMANS; HYPOKALEMIA; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; KAPLAN-MEIER ESTIMATE; MALE; POTASSIUM; PROPORTIONAL HAZARDS MODELS; RESPIRATORY SYSTEM AGENTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84883478438     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2012-303089     Document Type: Article

References (23)

1. Benard M, Boutroy MJ, Glorieux I, et al. Determinants of doxapram utilization: a survey of practice in the French Neonatal and Intensive Care Units. Arch Pediatr 2005;12:151-5. (Pubitemid 40247600)
2. Eyal F, Alpan G, Sagi E, et al . Aminophylline versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study. Pediatrics 1985;75:709-13. (Pubitemid 15079524)
3. Yamazaki T, Kajiwara M, Itahashi K, et al. Low-dose doxapram therapy for idiopathic apnea of prematurity. Pediatr Int 2001;43:124-7. (Pubitemid 32378518)
4. Bhatia J. Current options in the management of apnea of prematurity. Clin Pediatr 2000;39:327-36. (Pubitemid 30399622)
5. Mitchell RA, Herbert DA. Potencies of doxapram and hypoxia in stimulating carotid-body chemoreceptors and ventilation in anesthetized cats. Anesthesiology 1975;42:559-66.
6. Barrington KJ, Finer NN, Peters KL, et al. Physiologic effects of doxapram in idiopathic apnea of prematurity. J Pediatr 1986;108:124-9. (Pubitemid 16126049)
7. Hall KW, Dobson KE, Dalton JG, et al. Metabolic abnormalities associated with intentional theophylline overdose. Ann Intern Med 1984;101:457-62. (Pubitemid 14018039)
8. Passmore AP, Kondowe GB, Johnston GD. Caffeine and hypokalemia. Ann Intern Med 1986;105:468. (Pubitemid 16014329)
9. Suki W, Rector FC Jr, Seldin DW. The site of action of furosemide and other sulfonamide diuretics in the dog. J Clin Invest 1965;44:1458-69.
10. Roberts KE. Sulfonamyl diuretics - Mechanism of action and therapeutic use. Calif Med 1964;100:160-4.
11. Manning RT, Behrle FC. Use of spironolactone in renal edema. Effectiveness and association with hyperkalemia. JAMA 1961;176:769-71.
12. Omar SA, DeCristofaro JD, Agarwal BI, et al. Effect of prenatal steroids on potassium balance in extremely low birth weight neonates. Pediatrics 2000;106:561-7. (Pubitemid 30664144)
13. Marasco WA, Gikas PW, Azziz-Baumgartner R, et al. Ibuprofen-associated renal dysfunction. Pathophysiologic mechanisms of acute renal failure, hyperkalemia, tubular necrosis, and proteinuria. Arch Intern Med 1987;147:2107-16. (Pubitemid 18008713)
14. Silva P, Brown RS, Epstein FH. Adaptation to potassium. Kidney Int 1977;11:466-75. (Pubitemid 8129231)
15. Semama DS. Diuretics in preterm infants. Arch Pediatr 2006;13:379-87.
16. 2P) potassium channel function but does not affect minimum alveolar anesthetic concentration. Anesth Analg 2006;102:779-85.
17. Henderson-Smart DJ, Steer P. Doxapram versus methylxanthine for apnea in preterm infants. Cochrane Database Syst Rev 2000;(4):CD000075.
18. Tay-Uyboco J, Kwiatkowski K, Cates DB, et al. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity. Biol Neonate 1991;59:190-200.
19. Dear PR, Wheeler D. Doxapram and neonatal apnoea. Arch Dis Child 1984;59:903-4.
20. Maillard C, Boutroy MJ, Fresson J, et al. QT interval lengthening in premature infants treated with doxapram. Clin Pharmacol Ther 2001;70:540-5. (Pubitemid 34008411)
21. Lando A, Klamer A, Jonsbo F, et al . Doxapram and developmental delay at 12 months in children born extremely preterm. Acta Paediatr 2005;94:1680-1. (Pubitemid 41754327)
22. Dani C, Bertini G, Pezzati M, et al. Brain hemodynamic effects of doxapram in preterm infants. Biol Neonate 2006;89:69-74. (Pubitemid 43254160)
23. Gouyon JB, Bernardini S, Semama DS, et al. Salt depletion and dehydration in hypertensive preterm infants. Pediatr Nephrol 1997;11:201-4. (Pubitemid 27122692)